Pfizer, Inc. (NYSE:PFE)

CAPS Rating: 4 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Results 161 - 180 of 994 : « Previous 4 5 6 7 8 9 10 11 12 13 Next »

Recs

0
Member Avatar stuinkc (74.07) Submitted: 10/22/2009 9:44:11 AM : Outperform Start Price: $15.61 PFE Score: +19.17

value, dividend

Recs

0
Member Avatar vshar (< 20) Submitted: 10/21/2009 2:47:38 PM : Outperform Start Price: $15.81 PFE Score: +19.71

After healthcare reforms the pimps will be gone and the benefit will go to the patients and indirectly to the pharmacuticals

Recs

0
Member Avatar Nostradamuss (< 20) Submitted: 10/20/2009 9:03:58 AM : Outperform Start Price: $16.34 PFE Score: +15.26

++

Recs

0
Member Avatar fjm1502 (46.22) Submitted: 10/12/2009 5:52:22 PM : Outperform Start Price: $15.10 PFE Score: +23.53

Awesome company with 15 plus pending FDA approval for drugs.

Recs

0
Member Avatar joker11b (< 20) Submitted: 10/7/2009 9:23:51 AM : Outperform Start Price: $14.97 PFE Score: +22.37

Flu epidemic. Current proposal to FDA over HIV medicine.

Recs

0
Member Avatar SequoiaStocks (86.21) Submitted: 9/18/2009 10:22:05 AM : Outperform Start Price: $14.86 PFE Score: +24.99

This account tracks the performance of the investment firm Ruane, Cunniff, and Goldfarb - the investment manager of Sequoia Fund.

Recs

0
Member Avatar hirooshivam (< 20) Submitted: 9/8/2009 4:59:02 PM : Outperform Start Price: $14.54 PFE Score: +23.51

global name known for decades and their research will get this stock ahead of their competitors

Recs

0
Member Avatar zsanabri (< 20) Submitted: 8/26/2009 6:49:10 PM : Outperform Start Price: $14.89 PFE Score: +19.91

worked for the company for 28 years

Recs

0
Member Avatar charlesumeugokwe (< 20) Submitted: 8/25/2009 2:34:42 PM : Outperform Start Price: $15.00 PFE Score: +18.73

astounding balance sheet

Recs

0
Member Avatar cashandgrab (< 20) Submitted: 8/24/2009 6:31:29 PM : Outperform Start Price: $14.98 PFE Score: +19.33

Drug companies manufacture money in the form of little pills. The population is getting older and needs more pills to keep going, ergo: more money for Pfizer.

Recs

0
Member Avatar Bdalessi (35.84) Submitted: 8/14/2009 3:54:16 PM : Outperform Start Price: $14.06 PFE Score: +24.90

Undervalued on a long term basis.

Recs

0
Member Avatar Mantford1 (74.01) Submitted: 8/7/2009 3:41:20 PM : Outperform Start Price: $14.22 PFE Score: +23.91

Strong dividend play with good upside potential.

Recs

0
Member Avatar kaching58 (< 20) Submitted: 8/5/2009 8:18:02 AM : Outperform Start Price: $14.29 PFE Score: +23.17

Its sucess in frontline leading edge drug research and development beats the street. Its way ahead of the others in its field.

Recs

0
Member Avatar etrader09 (< 20) Submitted: 8/4/2009 1:07:00 PM : Outperform Start Price: $14.14 PFE Score: +24.24

This stock has a lot going for it at this cheap price. Has more positives than negative and will be a stable American company for years to come. Also has capital to swallow up other companies in the future.

Recs

0
Member Avatar aikiboy2k (39.70) Submitted: 8/4/2009 12:54:24 PM : Outperform Start Price: $14.18 PFE Score: +23.64

Pfizer has the resources to buy up the assets it needs to rebound.

Recs

0
Member Avatar shastashadow (91.42) Submitted: 8/4/2009 12:40:32 PM : Outperform Start Price: $14.20 PFE Score: +23.92

Baby boomers are getting older and what do they like to take? Drugs, drugs, and more drugs.

Recs

0
Member Avatar d52lusk (66.95) Submitted: 8/1/2009 9:17:44 PM : Outperform Start Price: $14.30 PFE Score: +21.90

high future earnings potential

Recs

0
Member Avatar DogOfDow (83.58) Submitted: 7/28/2009 9:20:23 AM : Outperform Start Price: $14.46 PFE Score: +17.12

Just testing out a theory.

Recs

0
Member Avatar StockOx (< 20) Submitted: 7/27/2009 4:32:53 PM : Outperform Start Price: $13.27 PFE Score: +41.11

people need drugs no matter the economy, add they will have to pay for them

Recs

0
Member Avatar pchristoph (< 20) Submitted: 7/27/2009 4:00:29 AM : Outperform Start Price: $14.54 PFE Score: +16.56

Low fwd p/e, great margins, good debt position makes this a reasonably priced blue chip. Solid dividend is a bonus.

Featured Broker Partners


Advertisement